Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues [Abstract]
Revenue	$ 270,600	$ 50,037
Operating expenses:
Cost of revenue (excluding amortization and depreciation)	26,065	5,198
Research and development	97,944	57,947	$ 58,061
Selling, general and administrative	323,123	159,254	66,646
Loss in fair value of contingent consideration	48,918	3,298
Intangible asset amortization	6,375	4,139
Total operating expenses	502,425	229,836	124,707
Loss from operations	(231,825)	(179,799)	(124,707)
Interest expense, net	(6,453)	(7,335)	(5,696)
Loss before income taxes	(238,278)	(187,134)	(130,403)
Income tax expense	(960)
Net loss	$ (239,238)	$ (187,134)	$ (130,403)
Net loss per common share, basic	$ (5.27)	$ (4.60)	$ (3.47)
Net loss per common share, diluted	$ (5.27)	$ (4.60)	$ (3.47)
Weighted average common shares outstanding, basic	45,425,212	40,655,941	37,618,599
Weighted average common shares outstanding, diluted	45,425,212	40,655,941	37,618,599
Product Sales
Revenues [Abstract]
Revenue	$ 202,460	$ 50,037
License Revenue
Revenues [Abstract]
Revenue	65,735
Royalty Revenue
Revenues [Abstract]
Revenue	$ 2,405